Clinical trial
A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With…
NCT00002308 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00002308 |
|---|---|
| Title | A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs |
| Official title | A Randomized Blinded Evaluation of Two Doses of Stavudine (2',3'-Didehydro-2',3'-Dideoxythymidine; d4T) to Make Treatment Available to Severely Immunocompromised Patients With HIV Infection Who Have Failed or Are Intolerant of Alternative Antiretroviral Therapy |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Stavudine |
| Completion | Nov 1, 1991 |
| First posted | Aug 31, 2001 |
| Last update posted | Aug 5, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: